StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Harvard Bioscience's revenue for the twelve months ending Jun 30, 2026 was $87.81M, down 1.1% year over year. For fiscal 2025 it was $86.55M, down 8.1% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $120.77M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$86.55M-8.1%
FY2024Dec 31, 2024$94.14M-16.1%
FY2023Dec 31, 2023$112.25M-1.0%
FY2022Dec 31, 2022$113.34M-4.7%
FY2021Dec 31, 2021$118.90M+16.5%
FY2020Dec 31, 2020$102.10M-12.1%
FY2019Dec 31, 2019$116.18M-3.8%
FY2018Dec 31, 2018$120.77M+56.0%
FY2017Dec 31, 2017$77.41M-25.9%
FY2016Dec 31, 2016$104.52M-3.8%
FY2015Dec 31, 2015$108.66M+0.0%
FY2014Dec 31, 2014$108.66M+3.3%
FY2013Dec 31, 2013$105.17M-5.4%
FY2012Dec 31, 2012$111.17M+2.1%
FY2011Dec 31, 2011$108.86M+0.6%
FY2010Dec 31, 2010$108.18M+26.1%
FY2009Dec 31, 2009$85.77M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.73M+11.1%
Q1 FY2026Mar 31, 2026$20.76M-4.7%
Q4 FY2025Dec 31, 2025$23.74M-3.3%
Q3 FY2025Sep 30, 2025$20.59M-6.3%
Q2 FY2025Jun 30, 2025$20.45M-11.5%
Q1 FY2025Mar 31, 2025$21.77M-11.2%
Q4 FY2024Dec 31, 2024$24.56M-12.8%
Q3 FY2024Sep 30, 2024$21.97M-13.4%
Q2 FY2024Jun 30, 2024$23.10M-19.7%
Q1 FY2024Mar 31, 2024$24.51M-18.2%
Q4 FY2023Dec 31, 2023$28.15M-1.0%
Q3 FY2023Sep 30, 2023$25.36M-5.8%
Q2 FY2023Jun 30, 2023$28.76M-1.5%
Q1 FY2023Mar 31, 2023$29.98M+4.2%
Q4 FY2022Dec 31, 2022$28.43M-14.0%
Q3 FY2022Sep 30, 2022$26.92M-9.2%
Q2 FY2022Jun 30, 2022$29.21M+0.0%
Q1 FY2022Mar 31, 2022$28.78M+6.6%
Q4 FY2021Dec 31, 2021$33.06M+6.7%
Q3 FY2021Sep 30, 2021$29.66M+23.4%
Q2 FY2021Jun 30, 2021$29.20M+25.3%
Q1 FY2021Mar 31, 2021$26.99M+13.5%
Q4 FY2020Dec 31, 2020$30.98M+0.0%
Q3 FY2020Sep 30, 2020$24.04M-12.3%
Q2 FY2020Jun 30, 2020$23.31M-21.2%
Q1 FY2020Mar 31, 2020$23.77M-15.7%
Q4 FY2019Dec 31, 2019$30.97M-8.5%
Q3 FY2019Sep 30, 2019$27.42M-4.3%
Q2 FY2019Jun 30, 2019$29.58M-6.1%
Q1 FY2019Mar 31, 2019$28.20M+5.4%
Q4 FY2018Dec 31, 2018$33.86M+56.4%
Q3 FY2018Sep 30, 2018$28.64M+53.0%
Q2 FY2018Jun 30, 2018$31.52M+66.3%
Q1 FY2018Mar 31, 2018$26.76M+48.0%
Q4 FY2017Dec 31, 2017$21.65M-18.1%
Q3 FY2017Sep 30, 2017$18.72M-25.2%
Q2 FY2017Jun 30, 2017$18.96M–
Q1 FY2017Mar 31, 2017$18.09M–
Q4 FY2016Dec 31, 2016$26.42M–
Q3 FY2016Sep 30, 2016$25.01M–

More Harvard Bioscience figures

See a number that looks wrong?